PROFOUND MEDICAL CORP.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $7.2M | $52.6M | $46.5M |
| FY2023 | $5.0M | $31.2M | $26.2M |
| FY2024 | $2.9M | $60.4M | $54.9M |
| FY2025 | $4.5M | $66.4M | $59.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2022 | $7.2M | $52.6M | $46.5M |
| FY2023 | $5.0M | $31.2M | $26.2M |
| FY2024 | $2.9M | $60.4M | $54.9M |
| FY2025 | $4.5M | $66.4M | $59.7M |